I. Merkies

发表

The Domain II S4-S5 Linker in Nav1.9: A Missense Mutation Enhances Activation, Impairs Fast Inactivation, and Produces Human Painful Neuropathy

Yang Yang, Catharina G. Faber, Sulayman D. Dib-Hajj, 2015, NeuroMolecular Medicine.

Evaluation of scales and measurement instruments in immune-mediated polyneuropathies

I. Merkies, 2001 .

Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy

H. Hartung, G. Sobue, R. Lewis, 2021, CPT: pharmacometrics & systems pharmacology.

Pain and autonomic dysfunction in patients with sarcoidosis and small fibre neuropathy

G. Lauria, M. D. de Baets, M. Drent, 2010, Journal of Neurology.

Small‐fiber neuropathy: Expanding the clinical pain universe

S. Waxman, G. Lauria, J. Hoeijmakers, 2019, Journal of the peripheral nervous system : JPNS.

Small Fiber Neuropathy in Children: Two Case Reports Illustrating the Importance of Recognition

J. Vles, J. Hoeijmakers, I. Merkies, 2016, Pediatrics.

Differential effect of lacosamide on Nav1.7 variants from responsive and non-responsive patients with small fibre neuropathy

H. Smeets, S. Dib-Hajj, S. Waxman, 2020, Brain : a journal of neurology.

Lacosamide in patients with Nav1.7 mutations-related small fibre neuropathy: a randomized controlled trial

S. Dib-Hajj, S. Waxman, J. Hoeijmakers, 2019, Brain : a journal of neurology.

Yield of peripheral sodium channels gene screening in pure small fibre neuropathy

H. Smeets, S. Waxman, G. Lauria, 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

No Fabry Disease in Patients Presenting with Isolated Small Fiber Neuropathy

H. Smeets, E. Wolters, A. van den Wijngaard, 2016, PloS one.

Painful neuropathies: the emerging role of sodium channelopathies

S. Waxman, J. Hoeijmakers, M. Gerrits, 2014, Journal of the peripheral nervous system : JPNS.

Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial

I. Merkies, 2013, Neurology.

Gain-of-function mutations in sodium channel Na(v)1.9 in painful neuropathy.

S. Dib-Hajj, S. Waxman, G. Lauria, 2014, Brain : a journal of neurology.

Safety and tolerability of immune globulin intravenous in chronic inflammatory demyelinating polyradiculoneuropathy.

H. Hartung, R. Hughes, M. Dalakas, 2010, Archives of neurology.

Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial

W. Robberecht, B. Tackenberg, C. Sommer, 2017, Journal of the peripheral nervous system : JPNS.

230th ENMC International Workshop: Improving future assessment and research in IgM anti-MAG peripheral neuropathy: A consensus collaborative effort, Naarden, The Netherlands, 24–26 February 2017

P. Bergh, A. Steck, H. Willison, 2017, Neuromuscular Disorders.

Outcome measures in peripheral neuropathies: requirements through statements.

G. Lauria, I. Merkies, C. Faber, 2012, Current opinion in neurology.

Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

H. Hartung, R. Hughes, M. Dalakas, 2008, The Lancet Neurology.

H. Hartung, R. Hughes, M. Dalakas, 2009, Neurology.

Intraepidermal nerve fiber density and its application in sarcoidosis

G. Lauria, M. D. de Baets, R. Lombardi, 2009, Neurology.

Getting closer to patients: the INCAT Overall Disability Sum Score relates better to patients’ own clinical judgement in immune-mediated polyneuropathies

P. Schmitz, I. Merkies, I. Merkies, 2006, Journal of Neurology, Neurosurgery & Psychiatry.

Challenges of clinical trial design when there is lack of clinical equipoise: use of a response-conditional crossover design

H. Hartung, M. Dalakas, V. Bril, 2011, Journal of Neurology.

Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study

Y. Pinto, S. Schalla, G. Snoep, 2012, Journal of Cardiovascular Magnetic Resonance.

Electrical spinal cord stimulation in painful diabetic polyneuropathy, a systematic review on treatment efficacy and safety.

M. van Kleef, A. Kessels, N. Schaper, 2011, European journal of pain.

The G1662S NaV1.8 mutation in small fibre neuropathy: impaired inactivation underlying DRG neuron hyperexcitability

S. Dib-Hajj, S. Waxman, Chongyang Han, 2013, Journal of Neurology, Neurosurgery & Psychiatry.

Sodium channel Nav1.7 in vascular myocytes, endothelium, and innervating axons in human skin

S. Waxman, F. Rice, J. A. Black, 2015, Molecular pain.

EuropeanFederationofNeurologicalSocieties/PeripheralNerve SocietyGuidelineontheuseofskinbiopsyinthediagnosisofsmall fiberneuropathy.ReportofajointtaskforceoftheEuropeanFe- derationofNeurologicalSocietiesandthePeripheralNerveSociety

M. Nolano, C. Sommer, S. Mellgren, 2010 .

Small nerve fibres, small hands and small feet: a new syndrome of pain, dysautonomia and acromesomelia in a kindred with a novel NaV1.7 mutation.

S. Dib-Hajj, S. Waxman, G. Lauria, 2012, Brain : a journal of neurology.

Associated conditions in small fiber neuropathy – a large cohort study and review of the literature

I. S. J. Merkies, J. Hoeijmakers, I. Merkies, 2017, European journal of neurology.

Norfolk QOL‐DN: validation of a patient reported outcome measure in transthyretin familial amyloid polyneuropathy

A. Vinik, J. Paulson, T. Coelho, 2014, Journal of the peripheral nervous system : JPNS.

Diagnostic value of symptoms in chronic polyneuropathy: The Erasmus Polyneuropathy Symptom Score

M. Ikram, M. Van Oijen, P. V. van Doorn, 2019, Journal of the peripheral nervous system : JPNS.

Does ability to walk reflect general functionality in inflammatory neuropathies?

D. Cornblath, P. Doorn, I. Merkies, 2016, Journal of the peripheral nervous system : JPNS.

Reliability and responsiveness of a graduated tuning fork in immune mediated polyneuropathies

P. Schmitz, P. V. van Doorn, P. Doorn, 2000, Journal of neurology, neurosurgery, and psychiatry.

Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial

T. Heskes, P. Donnan, J. Deux, 2018, The Lancet Neurology.

Protocol of a dose response trial of IV immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (DRIP study)

E. Brusse, B. Jacobs, A. J. van der Kooi, 2018, Journal of the peripheral nervous system : JPNS.

Treatment of multifocal motor neuropathy with interferon-β1A

L. H. van den Berg, R. M. Van den Berg-Vos, H. Franssen, 2000, Neurology.

Intra- and interfamily phenotypic diversity in pain syndromes associated with a gain-of-function variant of NaV1.7

S. Dib-Hajj, S. Waxman, G. Lauria, 2011, Molecular pain.

Analysis of relapse by inflammatory Rasch‐built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy

H. Hartung, G. Sobue, R. Lewis, 2022, Journal of the peripheral nervous system : JPNS.

Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre‐randomization phase of the Polyneuropathy And Treatment with Hizentra study

D. Yarnitsky, M. Valis, H. Hartung, 2019, Journal of the peripheral nervous system : JPNS.

Gain-of-function Nav1.8 mutations in painful neuropathy

S. Dib-Hajj, S. Waxman, G. Lauria, 2012, Proceedings of the National Academy of Sciences.

Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice

G. Parry, R. Lewis, R. Hughes, 2010, Journal of the peripheral nervous system : JPNS.

Patients' and physicians' interpretation of chemotherapy‐induced peripheral neurotoxicity

T. Postma, M. Valsecchi, L. Padua, 2019, Journal of the peripheral nervous system : JPNS.

Incidence and prevalence of small-fiber neuropathy

J. Hoeijmakers, I. Merkies, C. Faber, 2013, Neurology.

Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial

Hester F. Lingsma, E. Steyerberg, R. Hughes, 2021, The Lancet Neurology.

Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP

H. Hartung, G. Sobue, R. Lewis, 2019, Neurology: Neuroimmunology & Neuroinflammation.

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

G. L. Masson, D. Yarnitsky, S. Muley, 2018, The Lancet Neurology.

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP), a multicenter randomized double-blind placebo-controlled trial: the Path study

H. Hartung, G. Sobue, V. Bril, 2017, Journal of the Neurological Sciences.

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial

H. Hartung, G. Sobue, R. Lewis, 2016, Trials.

Electrophysiologic correlations with clinical outcomes in CIDP

H. Hartung, R. Hughes, M. Dalakas, 2010, Muscle & nerve.

Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIV

H. Hartung, R. Hughes, M. Dalakas, 2009, Muscle & nerve.

Functional profiles of SCN9A variants in dorsal root ganglion neurons and superior cervical ganglion neurons correlate with autonomic symptoms in small fibre neuropathy.

S. Dib-Hajj, S. Waxman, G. Lauria, 2012, Brain : a journal of neurology.

Treatment of multifocal motor neuropathy with interferon-beta1A.

L. H. van den Berg, R. M. Van den Berg-Vos, H. Franssen, 2000, Neurology.

Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy

R. D. de Haan, M. Dijkgraaf, L. Visser, 2022, Brain : a journal of neurology.

IqYmune® is an effective maintenance treatment for multifocal motor neuropathy: A randomised, double‐blind, multi‐center cross‐over non‐inferiority study vs Kiovig®—The LIME Study

D. Cocito, J. Pouget, I. Merkies, 2018, Journal of the peripheral nervous system : JPNS.

Maintenance IV immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy

E. Brusse, B. Jacobs, A. J. van der Kooi, 2017, Journal of the peripheral nervous system : JPNS.

A case of Guillain-Barré syndrome following a family outbreak of Campylobacter jejuni enteritis

H. Endtz, B. Jacobs, R. Koningsveld, 2000, Journal of Neuroimmunology.

Fatigue in immune-mediated polyneuropathies

P. Schmitz, J. Samijn, P. V. van Doorn, 1999, Neurology.

Comment on research report by Gruson and colleagues, this issue

C. Huff, R. Hughes, D. Cornblath, 2011, Journal of the peripheral nervous system : JPNS.

Pain accompanies pure motor Guillain‐Barré syndrome

J. Meulstee, J. D. Botero, P. V. van Doorn, 2008, Journal of the peripheral nervous system : JPNS.

Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial

G. L. Masson, C. Ervin, H. Hartung, 2018, The Lancet Neurology.

Gain of function NaV1.7 mutations in idiopathic small fiber neuropathy

S. Dib-Hajj, S. Waxman, G. Lauria, 2012, Annals of neurology.

Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial–the LENSS study

J. Hoeijmakers, I. Merkies, C. Faber, 2016, Trials.

Ca2+ toxicity due to reverse Na+/Ca2+ exchange contributes to degeneration of neurites of DRG neurons induced by a neuropathy-associated Nav1.7 mutation.

S. Waxman, J. A. Black, G. Lauria, 2015, Journal of neurophysiology.

Ca 2 toxicity due to reverse Na / Ca 2 exchange contributes to degeneration of neurites of DRG neurons induced by a neuropathy-associated Nav 1 . 7 mutation

S. Waxman, J. A. Black, G. Lauria, 2015 .

Quality of life complements traditional outcome measures in immune-mediated polyneuropathies

P. Schmitz, J. Samijn, P. V. van Doorn, 2002, Neurology.

Proceed with caution: Benefits and drawbacks of modern clinimetric analysis

I. Merkies, I. Merkies, Tatiana Hamadeh, 2022, Developmental medicine and child neurology.

Advances in diagnostics and outcome measures in peripheral neuropathies

G. Lauria, I. Merkies, C. Faber, 2015, Neuroscience Letters.

Comparison between impairment and disability scales in immune‐mediated polyneuropathies

P. Schmitz, P. V. van Doorn, I. Merkies, 2003, Muscle & nerve.

Small fibre neuropathy.

G. Lauria, I. Merkies, C. Faber, 2012, Current opinion in neurology.

NaV1.7: Stress-induced changes in immunoreactivity within magnocellular neurosecretory neurons of the supraoptic nucleus

S. Waxman, J. A. Black, J. Hoeijmakers, 2013, Molecular pain.

A painful neuropathy-associated Nav1.7 mutant leads to time-dependent degeneration of small-diameter axons associated with intracellular Ca2+ dysregulation and decrease in ATP levels

S. Waxman, G. Lauria, J. Hoeijmakers, 2016, Molecular pain.

Network topology of NaV1.7 mutations in sodium channel-related painful disorders

Filippo Martinelli-Boneschi, Andrea Zauli, Ronald L. Westra, 2017, BMC Systems Biology.

Evaluation of molecular inversion probe versus TruSeq® custom methods for targeted next-generation sequencing

H. Smeets, S. Dib-Hajj, S. Waxman, 2020, PloS one.

Reconstructing the Rasch-Built Myotonic Dystrophy Type 1 Activity and Participation Scale

J. Hoeijmakers, I. Merkies, C. Faber, 2015, PloS one.

Measures of chemotherapy‐induced peripheral neuropathy: a systematic review of psychometric properties

D. Cornblath, I. Merkies, K. Griffith, 2010, Journal of the peripheral nervous system : JPNS.

How to assess new drugs for neuropathies: advances in trial design and methodology

P. V. van Doorn, I. Merkies, 2008, Current opinion in neurology.

Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies

P. V. van Doorn, P. Schmitz, I. Merkies, 2000, Neurology.

Outcome measures in immune‐mediated neuropathies: the need to standardize their use and to understand the clinimetric essentials

I. Merkies, C. Faber, S. I. van Nes, 2008, Journal of the peripheral nervous system : JPNS.

Epidermal innervation morphometry by immunofluorescence and bright‐field microscopy

L. Santoro, M. Nolano, V. Provitera, 2015, Journal of the peripheral nervous system : JPNS.

Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study

C. Schmitz, S. Mellgren, G. Lauria, 2010, Journal of the peripheral nervous system : JPNS.

Activities of daily living in myotonic dystrophy type 1

H. Lochmüller, C. Jimenez-Moreno, S. Cumming, 2019, Acta neurologica Scandinavica.

Pain triangle phenomenon in possible association with SCN9A: A case report

A. J. van der Kooi, J. Hoeijmakers, I. Merkies, 2022, Molecular genetics & genomic medicine.

A gain-of-function sodium channel β2-subunit mutation in painful diabetic neuropathy

S. Dib-Hajj, S. Waxman, G. Lauria, 2019, Molecular pain.

Sodium channel genes in pain-related disorders: phenotype–genotype associations and recommendations for clinical use

C. Woods, S. Dib-Hajj, S. Waxman, 2014, The Lancet Neurology.

The Role of Sodium Channels in Painful Diabetic and Idiopathic Neuropathy

S. Waxman, G. Lauria, R. Malik, 2014, Current Diabetes Reports.

Painful peripheral neuropathy and sodium channel mutations

S. Waxman, J. Hoeijmakers, I. Merkies, 2015, Neuroscience Letters.

Monoclonal gammopathy associated neuropathy: Focusing on IgM M-protein associated neuropathy

I. Merkies, N. Notermans, Mariëlle H. J. Pruppers, 2020 .

Revised normative values for grip strength with the Jamar dynamometer

P. V. van Doorn, I. Merkies, C. Faber, 2011, Journal of the peripheral nervous system : JPNS.

Confirming the efficacy of intravenous immunoglobulin in CIDP through minimum clinically important differences: shifting from statistical significance to clinical relevance

R. Hughes, C. Deng, I. Merkies, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small Fiber Neuropathy

S. V. van Kuijk, J. Hoeijmakers, I. Merkies, 2021, Neurology.

Intravenous immunoglobulin therapy for small fiber neuropathy: study protocol for a randomized controlled trial

J. Hoeijmakers, I. Merkies, C. Faber, 2016, Trials.

Neuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future Prospects

M. van Kleef, J. Hoeijmakers, I. Merkies, 2015, Drugs & Aging.

Recent advances in outcome measures in IgM-anti-MAG+ neuropathies.

I. Merkies, N. Notermans, Mariëlle H. J. Pruppers, 2015, Current opinion in neurology.

Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses

L. H. van den Berg, G. Lauria, J. Pouget, 2015, Journal of the peripheral nervous system : JPNS.

MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1

Nick C Fox, T. Heskes, C. Kennard, 2019, Brain : a journal of neurology.

Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies

P. Schmitz, J. Samijn, P. V. van Doorn, 2002, Journal of neurology, neurosurgery, and psychiatry.

Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies

M. Bakkers, P. V. van Doorn, I. Merkies, 2011, Neurology.

Fatigue, Pain, Anxiety and Depression in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy

B. Kieseier, I. Merkies, 2016, European Neurology.

Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study

H. Hartung, M. Dalakas, V. Bril, 2010, Journal of the peripheral nervous system : JPNS.

Rasch‐Transformed Total Neuropathy Score clinical version (RT‐TNSc©) in patients with chemotherapy‐induced peripheral neuropathy

G. Cavaletti, D. Cornblath, I. Merkies, 2015, Journal of the peripheral nervous system : JPNS.

Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.

H. Hartung, R. Hughes, M. Dalakas, 2010, Archives of neurology.

Monitoring Clinical Course and Treatment Response in Chronic Inflammatory Demyelinating Polyneuropathy During Routine Care: A Review of Clinical and Laboratory Assessment Measures.

R. Lewis, Jeffrey A. Allen, I. Merkies, 2020, JAMA neurology.

Follow‐up nerve conduction studies in CIDP after treatment with IGIV‐C: Comparison of patients with and without subsequent relapse

H. Hartung, M. Dalakas, V. Bril, 2015, Muscle & nerve.

Small-fibre neuropathies—advances in diagnosis, pathophysiology and management

Catharina G. Faber, Stephen G. Waxman, Giuseppe Lauria, 2012, Nature Reviews Neurology.

The facioscapulohumeral muscular dystrophy Rasch‐built overall disability scale (FSHD‐RODS)

C. Horlings, J. Statland, B. V. van Engelen, 2021, European journal of neurology.

Rasch analysis to evaluate the motor function measure for patients with facioscapulohumeral muscular dystrophy

C. Horlings, B. V. van Engelen, I. Merkies, 2020, International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation.

Change over time in ability to perform activities of daily living in myotonic dystrophy type 1

H. Lochmüller, C. Jimenez-Moreno, S. Cumming, 2020, Journal of Neurology.

Impairment measures versus inflammatory RODS in GBS and CIDP: a responsiveness comparison

L. H. van den Berg, G. Lauria, J. Pouget, 2015, Journal of the peripheral nervous system : JPNS.

The Val30Met familial amyloid polyneuropathy specific Rasch‐built overall disability scale (FAP‐RODS©)

T. Coelho, A. M. da Silva, I. Merkies, 2015, Journal of the peripheral nervous system : JPNS.

Channelopathies, painful neuropathy, and diabetes: which way does the causal arrow point?

S. Waxman, J. Hoeijmakers, I. Merkies, 2014, Trends in molecular medicine.

Small-Fiber Neuropathy Nav1.8 Mutation Shifts Activation to Hyperpolarized Potentials and Increases Excitability of Dorsal Root Ganglion Neurons

Yang Yang, Stephen G Waxman, S. Dib-Hajj, 2013, The Journal of Neuroscience.

The minimum clinically important difference: which direction to take

I. Merkies, C. Faber, B. D. de Greef, 2019, European journal of neurology.

Physical training and fatigue, fitness, and quality of life in Guillain–Barré syndrome and CIDP

J. Bussmann, H. Stam, P. Schmitz, 2004, Neurology.

Small fiber neuropathies: expanding their etiologies

J. Hoeijmakers, I. Merkies, C. Faber, 2022, Current opinion in neurology.

COL6A5 variants in familial neuropathic chronic itch

S. Dib-Hajj, S. Waxman, M. Cocca, 2017, Brain : a journal of neurology.

Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review

H. Hartung, G. Sobue, R. Lewis, 2020, Journal of the peripheral nervous system : JPNS.

Connecting impairment, disability, and handicap in immune mediated polyneuropathies

P. Schmitz, J. Samijn, P. V. van Doorn, 2003, Journal of neurology, neurosurgery, and psychiatry.

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies

G. L. Masson, D. Yarnitsky, M. Valis, 2019, Journal of the peripheral nervous system : JPNS.

Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP

H. Hartung, G. Sobue, R. Lewis, 2019, Neurology: Neuroimmunology & Neuroinflammation.

Quantifying Treatment-Related Fluctuations in CIDP

M. Fiecas, S. Ajroud‐Driss, R. Lewis, 2021, Neurology.

Grip strength comparison in immune‐mediated neuropathies: Vigorimeter vs. Jamar

L. H. van den Berg, R. Lewis, G. Lauria, 2015, Journal of the peripheral nervous system : JPNS.

Rasch‐built Overall Disability Scale for Multifocal motor neuropathy (MMN‐RODS©)

L. H. van den Berg, D. Cornblath, W. L. van der Pol, 2015, Journal of the peripheral nervous system : JPNS.

Randomized trial of three IVIg doses for treating chronic inflammatory demyelinating polyneuropathy

H. Hartung, S. Budrewicz, M. Piradov, 2022, Brain : a journal of neurology.

Electrophysiological Testing in Patients with Chronic Inflammatory Demyelinating Polyneuropathy Treated with Subcutaneous Immunoglobulin: The PATH Study (P1.433)

H. Hartung, G. Sobue, R. Lewis, 2018 .

Differential effect of D623N variant and wild-type Nav1.7 sodium channels on resting potential and interspike membrane potential of dorsal root ganglion neurons

S. Dib-Hajj, S. Waxman, M. Estacion, 2013, Brain Research.

Small fibers, large impact: Quality of life in small‐fiber neuropathy

G. Lauria, J. Hoeijmakers, I. Merkies, 2014, Muscle & nerve.

Oral Fingolimod in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (FORCIDP): Results from a Phase III Randomized Placebo-controlled Trial (S27.002)

H. Hartung, G. Sobue, R. Hughes, 2017 .

Changing outcome in inflammatory neuropathies

L. H. van den Berg, J. Pouget, G. Lauria, 2014, Neurology.

Rasch‐ionale for neurologists

J. Thonnard, I. Merkies, C. Faber, 2015, Journal of the peripheral nervous system : JPNS.

Expression of pathogenic SCN9A mutations in the zebrafish: A model to study small-fiber neuropathy

H. Smeets, S. Waxman, G. Lauria, 2019, Experimental Neurology.

Gastroenteritis-associated Guillain–Barré syndrome on the Caribbean Island Curaçao

H. Endtz, B. Jacobs, R. Koningsveld, 2001, Neurology.

Amantadine for treatment of fatigue in Guillain-Barré syndrome: a randomised, double blind, placebo controlled, crossover trial

P. Schmitz, B. Jacobs, P. V. van Doorn, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

Questionnaires and scales SFN Symptom Inventory

G. Lauria, I. Merkies, C. Faber, 2012 .

Contact heat evoked potentials: Normal values and use in small‐fiber neuropathy

V. Lagerburg, J. Reulen, A. Smit, 2015, Muscle & nerve.

Use of Skin Biopsy in the Diagnosis of Small Fibre Neuropathy

M. Nolano, J. Valls-Solé, C. Sommer, 2010 .

The applicability of the digit wrinkle scan to quantify sympathetic nerve function

J. Hoeijmakers, I. Merkies, C. Faber, 2022, Clinical neurophysiology practice.

Approach to small fiber neuropathy

S. Waxman, G. Lauria, I. Merkies, 2014 .

scale in immune mediated polyneuropathies Clinimetric evaluation of a new overall disability

P. Schmitz, J. Samijn, P. Doorn, 2006 .

Temperature threshold testing: a systematic review

H. Franssen, J. Reulen, I. Merkies, 2013, Journal of the peripheral nervous system : JPNS.

IgM anti‐MAG± peripheral neuropathy (IMAGiNe) study protocol: An international, observational, prospective registry of patients with IgM M‐protein peripheral neuropathies

D. Cornblath, Perry T C van Doormaal, A. Vrancken, 2023, Journal of the peripheral nervous system : JPNS.

The small fiber neuropathy NaV1.7 I228M mutation: impaired neurite integrity via bioenergetic and mitotoxic mechanisms, and protection by dexpramipexole.

S. Waxman, G. Lauria, J. Hoeijmakers, 2019, Journal of neurophysiology.

Neuropathy‐associated NaV1.7 variant I228M impairs integrity of dorsal root ganglion neuron axons

S. Waxman, I. Merkies, C. Faber, 2013, Annals of neurology.

The Domain II S4-S5 Linker in Nav1.9: A Missense Mutation Enhances Activation, Impairs Fast Inactivation, and Produces Human Painful Neuropathy

S. Dib-Hajj, S. Waxman, G. Lauria, 2015, NeuroMolecular Medicine.

Paroxysmal itch caused by gain-of-function Nav1.7 mutation

S. Waxman, G. Lauria, R. Eleopra, 2014, PAIN®.

Genetic Profiling of Sodium Channels in Diabetic Painful and Painless and Idiopathic Painful and Painless Neuropathies

S. Dib-Hajj, S. Waxman, E. Salvi, 2023, International journal of molecular sciences.

Diagnosis of neuropathic pain: challenges and possibilities.

S. Waxman, G. Lauria, I. Merkies, 2012, Expert opinion on medical diagnostics.

Sensory exam with a quantitative tuning fork: Rapid, sensitive and predictive of SNAP amplitude

P. Schmitz, P. V. van Doorn, I. Merkies, 2004, Neurology.

J. Verbunt, J. Hoeijmakers, I. Merkies, 2016, Journal of the peripheral nervous system : JPNS.

immune mediated polyneuropathies Connecting impairment, disability, and handicap in

P. Schmitz, J. Samijn, P. Doorn, 2006 .

Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy-Induced Peripheral Neurotoxicity

G. Cavaletti, A. Schenone, C. Briani, 2021, Neurology.

Validation of the Serbian version of inflammatory Rasch‐built overall disability scale in patients with chronic inflammatory demyelinating polyradiculoneuropathy

I. Bozovic, I. Merkies, C. Faber, 2019, Journal of the peripheral nervous system : JPNS.

Quality of life in inflammatory neuropathies: the IN-QoL

I. Merkies, C. Faber, T. H. Draak, 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

Improving fatigue assessment in immune‐mediated neuropathies: the modified Rasch‐built fatigue severity scale

P. V. van Doorn, I. Merkies, C. Faber, 2009, Journal of the peripheral nervous system : JPNS.

Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group.

P. Schmitz, J. Samijn, P. V. van Doorn, 1999, Neurology.

Outcome measures in MMN revisited: further improvement needed

L. H. van den Berg, W. L. van der Pol, I. Merkies, 2015, Journal of the peripheral nervous system : JPNS.

Small Fiber Neuropathy: A Clinical and Practical Approach

J. Hoeijmakers, I. Merkies, C. Faber, 2023, The Journal for Nurse Practitioners.

Correspondence between neurophysiological and clinical measurements of chemotherapy‐induced peripheral neuropathy: secondary analysis of data from the CI‐PeriNomS study

M. Johantgen, T. Postma, M. Valsecchi, 2014, Journal of the peripheral nervous system : JPNS.

IGM ANTI-MAG PERIPHERAL NEUROPATHY: FROM PROPER ASSESSMENT TO TRIAL NEEDS (IMAGINE STUDY)

I. Merkies, C. Faber, M. Lunn, 2016 .

Improving assessment in small fiber neuropathy

J. Hoeijmakers, I. Merkies, C. Faber, 2015, Journal of the peripheral nervous system : JPNS.

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings.

G. Altavilla, T. Postma, S. Galimberti, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Fe‐deration of Neurological Societies and the Peripheral Nerve Society

J. Valls-Solé, S. I. Mellgren, O. Johansson, 2010, European journal of neurology.

Peripheral neuropathy in myotonic dystrophy type 1

C. D. de Die-Smulders, M. D. de Baets, I. Merkies, 2011, Journal of the peripheral nervous system : JPNS.

Nav1.7-related small fiber neuropathy

S. Dib-Hajj, S. Waxman, G. Lauria, 2012, Neurology.

Small fibre neuropathy.

G. Lauria, I. Merkies, C. Faber, 2012, Current opinion in neurology.

The Pain Dynamics of Small Fiber Neuropathy.

M. van Kleef, S. V. van Kuijk, J. Hoeijmakers, 2018, The journal of pain : official journal of the American Pain Society.

Safety and Tolerability of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: Results of the ProCID Study

S. Budrewicz, D. Cornblath, M. Koszewicz, 2023, Drug Safety.

A randomised, multi‐centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol

H. Hartung, D. Cornblath, P. V. van Doorn, 2018, Journal of the peripheral nervous system : JPNS.

Untoward global effects of current guideline formulation of stereotactic radiotherapy for symptomatic brain metastases by international medical societies

I. Merkies, J. Schnog, D. E. de Vocht, 2023, Lancet regional health. Americas.

Paroxysmal itch caused by gain-of-function Nav1.7 mutation

S. Waxman, G. Lauria, R. Eleopra, 2014, PAIN®.

Sodium channel genes in pain-related disorders: phenotype–genotype associations and recommendations for clinical use

S. Dib-Hajj, G. Lauria, M. Gerrits, 2014, The Lancet Neurology.

Small nerve fibres, small hands and small feet: a new syndrome of pain, dysautonomia and acromesomelia in a kindred with a novel NaV1.7 mutation.

S. Dib-Hajj, S. Waxman, G. Lauria, 2012, Brain : a journal of neurology.

Outcome measures in MMN revisited: further improvement needed

L. H. van den Berg, W. L. van der Pol, I. Merkies, 2015, Journal of the peripheral nervous system : JPNS.

T. Coelho, I. Merkies, C. Faber, 2015, Journal of the peripheral nervous system.

Rasch‐Transformed Total Neuropathy Score clinical version (RT‐TNSc©) in patients with chemotherapy‐induced peripheral neuropathy

G. Cavaletti, D. Cornblath, I. Merkies, 2015, Journal of the peripheral nervous system : JPNS.

Confirming the efficacy of intravenous immunoglobulin in CIDP through minimum clinically important differences: shifting from statistical significance to clinical relevance

C. Deng, I. Merkies, S. I. Nes, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study

H. Hartung, M. Dalakas, V. Bril, 2010, Journal of the peripheral nervous system : JPNS.

Channelopathies, painful neuropathy, and diabetes: which way does the causal arrow point?

S. Waxman, J. Hoeijmakers, I. Merkies, 2014, Trends in molecular medicine.

Grip strength comparison in immune‐mediated neuropathies: Vigorimeter vs. Jamar

L. H. van den Berg, R. Lewis, G. Lauria, 2015, Journal of the peripheral nervous system : JPNS.

Sensory exam with a quantitative tuning fork: rapid, sensitive and predictive of SNAP amplitude.

P. Schmitz, P. V. van Doorn, I. Merkies, 2004, Neurology.

Morphometry of dermal nerve fibers in human skin

G. Lauria, J. Casanova-Mollá, G. Lauria, 2011, Neurology.

Statistische significantie of klinische relevantie

I. Merkies, C. Faber, E. Vanhoutte, 2010 .

Cost of illness of patients with small fiber neuropathy in the Netherlands

Y. van Eijk-Hustings, M. Joore, L. Brandts, 2023, Pain.

Transcranial magnetic stimulation for tinnitus : No better than sham treatment ?

H. Kamel, N. Hadjikhani, M. Gorno-Tempini, 2012 .

Follow‐up nerve conduction studies in CIDP after treatment with IGIV‐C: Comparison of patients with and without subsequent relapse

H. Hartung, M. Dalakas, V. Bril, 2015, Muscle & nerve.

Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.

H. Hartung, R. Hughes, M. Dalakas, 2010, Archives of neurology.

Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIV

H. Hartung, R. Hughes, M. Dalakas, 2009, Muscle & nerve.

Optimizing temperature threshold testing in small‐fiber neuropathy

J. Reulen, J. Hoeijmakers, I. Merkies, 2015, Muscle & nerve.

Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial

T. Heskes, P. Donnan, J. Deux, 2018, The Lancet Neurology.

The small fiber neuropathy—symptom inventory questionnaire (SFN‐SIQ) does not discriminate between patients with or without small fiber neuropathy

J. Hoeijmakers, I. Merkies, C. Faber, 2023, Journal of the peripheral nervous system : JPNS.

Epidermal Nerve Fibers

S. Waxman, G. Lauria, I. Merkies, 2014 .

Development, validation and feasibility of a Patient Satisfaction Questionnaire for evaluating the quality performance of a diagnostic small fibre neuropathy service: A qualitative study

J. Hoeijmakers, I. Merkies, C. Faber, 2024, Health expectations : an international journal of public participation in health care and health policy.

Electrophysiologic correlations with clinical outcomes in CIDP

H. Hartung, R. Hughes, M. Dalakas, 2010, Muscle & nerve.